Stock listing

BOATS:NPCE NeuroPace, Inc. Stock

US listing (BOATS) of NeuroPace, Inc. · home listing NASDAQ:NPCE

Follow NeuroPace, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:NPCE

$7.95 USD -0.27 (-3.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NPCE

Past year -41.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$7.85 – $8.29 USDNov 20, 2026
Volume
749,375 sharesNov 20, 2026
Market cap
$273.9M USDAt the close on Nov 20, 2026 · price × 34.45M shares outstanding
52-week range
$5.46 – $19.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.74M USDMedian day 125,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NeuroPace, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NPCE · Home$7.95 USD-0.27 (-3.3%)749,375$7.97$8.29$7.845$8.22Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NPCE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$7.95-0.27-3.3%$7.97$8.29$7.845749,375
$8.22+0.02+0.2%$8.56$8.56$7.93307,220
$8.20+0.23+2.9%$7.825$8.71$7.63679,806
$7.97+0.41+5.4%$7.49$8.18$7.051,768,216
$7.56-4.46-37.1%$6.25$7.71$5.466,105,800
$12.02-0.50-4.0%$12.52$12.67$11.90156,700
$12.52-0.17-1.3%$12.81$12.94$12.4689,300
$12.69-0.43-3.3%$13.09$13.35$12.65133,700
$13.12+0.62+5.0%$12.81$13.48$12.80235,700
$12.50-0.19-1.5%$12.69$13.01$12.14128,400
$12.69-0.65-4.9%$13.41$13.41$12.40122,000
$13.34+1.03+8.4%$12.79$13.94$12.79227,900
$12.31-0.03-0.2%$12.42$12.64$12.00199,800
$12.34+0.04+0.3%$12.50$12.69$12.31120,500
$12.30-0.71-5.5%$13.01$13.10$12.2580,900
$13.01+0.08+0.6%$13.12$13.45$12.94104,600
$12.93-0.09-0.7%$12.83$13.33$12.74189,500
$13.02+0.03+0.2%$13.03$13.16$12.9167,200
$12.99+0.08+0.6%$12.90$13.22$12.6467,300
$12.91-0.23-1.8%$12.76$13.07$12.7669,100
$13.14+0.09+0.7%$13.05$13.43$12.9297,900
$13.05-0.46-3.4%$13.51$13.69$13.0364,200
$13.51+0.74+5.8%$12.84$13.53$12.81116,900
$12.77+0.53+4.3%$12.28$12.80$12.16117,400
$12.24-0.54-4.2%$12.85$12.85$12.13156,300
$12.78+0.22+1.8%$12.51$13.00$12.5186,600
$12.56-0.12-0.9%$12.58$13.04$12.4890,000
$12.68-0.32-2.5%$13.06$13.27$12.6866,800
$13.00+0.33+2.6%$12.52$13.02$12.4863,300
$12.67+0.28+2.3%$12.39$12.70$12.3872,500
$12.39-0.37-2.9%$12.66$12.66$12.28142,600
$12.76+0.09+0.7%$12.58$13.06$12.51127,200
$12.67-0.55-4.2%$13.38$13.38$12.6683,000
$13.22+0.52+4.1%$12.64$13.26$12.50149,400
$12.70-0.45-3.4%$13.34$13.34$12.68120,400
$13.15-0.61-4.4%$13.81$13.81$13.05197,400
$13.76-0.18-1.3%$14.02$14.06$13.73120,900
$13.94-0.21-1.5%$14.14$14.45$13.77100,600
$14.15+0.09+0.6%$14.01$14.18$13.75134,300
$14.06+0.09+0.6%$13.95$14.18$13.75231,400
$13.97-0.24-1.7%$14.21$14.21$13.59186,000
$14.21-0.50-3.4%$14.71$14.87$14.17166,400
$14.71+0.17+1.2%$14.75$14.94$14.54160,200
$14.54+0.26+1.8%$14.36$14.66$14.1271,700
$14.28+0.13+0.9%$14.17$14.56$14.05235,500
$14.15+0.05+0.4%$14.34$14.34$13.97107,800
$14.10-0.15-1.1%$14.28$14.57$14.04116,100
$14.25-0.34-2.3%$14.48$14.49$14.0596,800
$14.59+0.55+3.9%$14.01$14.66$13.95125,900
$14.04+0.17+1.2%$14.04$14.13$13.82107,500
$13.87-0.63-4.3%$14.46$14.47$13.8373,000
$14.50-0.26-1.8%$14.68$14.77$14.4178,600
$14.76-0.14-0.9%$14.65$15.10$14.54105,200
$14.90+0.15+1.0%$14.62$14.90$14.4792,300
$14.75-0.44-2.9%$15.25$15.48$14.49141,500
$15.19+0.45+3.1%$14.75$15.56$14.68163,700
$14.74+0.09+0.6%$14.70$14.86$14.52132,800
$14.65+0.24+1.7%$14.41$14.67$14.24148,300
$14.41+0.28+2.0%$14.09$14.55$13.76129,400
$14.13-0.55-3.7%$14.60$14.81$14.07148,100
$14.68+0.52+3.7%$14.23$14.86$14.10172,800
$14.16+0.17+1.2%$14.04$14.27$13.97153,402
$13.99-0.04-0.3%$14.10$14.48$13.96117,660
$14.03+0.01+0.1%$14.14$14.22$13.87116,000
$14.02-0.62-4.2%$14.35$14.60$13.56191,800
Ticker
BOATS:NPCE
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All NeuroPace, Inc. news

NeuroPace, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
21 in the last 12 months · 118 in all · newest Nov 12, 2026 · oldest 2021
Calls
23 calls with a replay · 23 with a transcript · latest Nov 12, 2026
Decks
8 decks · latest Aug 11, 2026

Where NeuroPace, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NPCE · Home listingNASDAQUnited StatesUSD
BOATS:NPCE · This pageBOATSUnited StatesUSD

Valuation

EV/sales 2.8× against a median of 2.6×: 6th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$283.8M USD
P/E
Loss
EV/sales
2.8×
EV/EBITDA
Negative EBITDA
Price/book
23.8×
Gross margin
78.9%
Operating margin
−11.5%
Net margin
−18.4%
Debt to equity
5.2×
Beta vs S&P 500
1.23

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NeuroPace, Inc. · NASDAQ:NPCEUS$273.9MUS$283.8Mn/a2.8×n/a23.8×−18.4%5.2×1.23
Chongqing Xishan Science and Technology Co., Ltd. Class A · SSE:688576US$301.5MUS$216.0Mn/a5.2×n/a1.2×−19.2%0.0×n/a
Sanara MedTech Inc. · NASDAQ:SMTIUS$299.1MUS$329.0Mn/a2.9×34.4×39.0×−2.7%6.1×0.49
Peijia Medical Ltd. · HKEX:9996US$297.8MUS$280.7Mn/a2.6×n/a1.1×−28.5%0.3×n/a
Jiangsu Apon Medical Technology Co. Ltd. Class A · SZSE:300753US$293.3MUS$281.1Mn/a5.8×n/a3.0×−9.1%0.0×n/a
Carvolix · EURONEXT:CVXUS$293.0MUS$306.6Mn/an/an/a6.2×n/a0.5×n/a
Treace Medical Concepts, Inc. · NASDAQ:TMCIUS$282.6MUS$302.8Mn/a1.5×n/a4.6×−27.4%1.0×2.03
PT Jayamas Medica Industri Tbk · IDX:OMEDUS$257.3MUS$192.4M10.5×1.4×6.4×1.6×18.2%0.1×n/a
SS Innovations International Inc. · NASDAQ:SSIIUS$254.7MUS$264.8Mn/a5.8×n/a5.1×−31.5%0.4×0.89
Orthofix Medical Inc. · NASDAQ:OFIXUS$247.4MUS$382.9Mn/a0.5×11.8×0.6×−5.4%0.5×1.09
Dentium Co., Ltd. · KRX:145720US$242.5MUS$224.9M10.8×0.9×3.1×0.6×8.6%0.1×n/a
Median of the othersUS$287.8MUS$280.9M10.7×2.6×9.1×2.3×−9.1%0.4×0.99

Forecasts

6 strong buy · 4 hold · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
12.33 USD · Analysts' mean
EPS, year to Dec 2026
-0.41 · 6 analysts
Revenue, year to Dec 2026
91.29M · 8 analysts

Team and board

Officers

OfficerRole
Joel D. BeckerCEO and Board Member
Patrick F. WilliamsChief Financial Officer
Leah AkinGeneral Counsel & Corporate Secretary
Scott SchaperHead of Investor Relations
Martha MorrellChief Medical Officer

Board

DirectorRole
Joel D. BeckerCEO and Board Member

Events

Calls

CallWhenStatus
NeuroPace (NASDAQ:NPCE) Q3 2026 Earnings CallThu, Nov 12, 2026 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2026 Earnings CallTue, Aug 11, 2026 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q1 2026 Earnings CallTue, May 12, 2026 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q4 2025 Earnings CallTue, Mar 03, 2026 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2025 Earnings CallTue, Aug 12, 2025 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q1 2025 Earnings CallTue, May 13, 2025 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q4 2024 Earnings CallWed, Jan 15, 2025 · 7:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q3 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2024 Earnings CallTue, Aug 13, 2024 · 4:30 PM ETReplay
All 23 calls
CallWhenStatus
NeuroPace (NASDAQ:NPCE) Q1 2024 Earnings CallWed, May 08, 2024 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q4 2023 Earnings CallTue, Mar 05, 2024 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q3 2023 Earnings CallMon, Nov 06, 2023 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q1 2023 Earnings CallThu, May 04, 2023 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q4 2022 Earnings CallThu, Mar 02, 2023 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2022 Earnings CallThu, Aug 11, 2022 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q1 2022 Earnings CallThu, May 12, 2022 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q4 2021 Earnings CallThu, Mar 10, 2022 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q3 2021 Earnings CallWed, Nov 10, 2021 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q2 2021 Earnings CallThu, Aug 12, 2021 · 4:30 PM ETReplay
NeuroPace (NASDAQ:NPCE) Q1 2021 Earnings CallThu, Jun 03, 2021 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−37.1%
Q2 2026Aug 11, 2026 · After close−3.3%
Q1 2026May 13, 2026−0.1%
Q4 2025Mar 3, 2026 · After close+0.9%
Q3 2025Nov 4, 2025 · After close+38.1%
Q2 2025Aug 12, 2025 · After close+2.1%
Q1 2025May 13, 2025 · After close+20.5%
Q4 2024Mar 3, 2025 · After close+0.9%
Q3 2024Nov 12, 2024 · After close+28.1%
Q2 2024Aug 13, 2024 · After close−7.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close−36.8%
Q4 2023Mar 5, 2024 · After close−1.6%
Q3 2023Nov 6, 2023 · After close−1.8%
Q2 2023Aug 8, 2023 · After close+9.8%
Q1 2023May 4, 2023 · After close−0.8%
Q4 2022Mar 2, 2023 · After close−2.4%
Q3 2022Nov 8, 2022 · After close−17.0%
Q2 2022Aug 11, 2022 · After close−7.0%
Q1 2022May 12, 2022 · After close−1.8%
Q4 2021Mar 10, 2022 · After close+6.2%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings31 slidesAug 11, 2026
J.P. Morgan 44th Annual Healthcare Conference 2026Conference28 slidesJanuary 2026
Q1 2025 Earnings PresentationEarnings27 slidesMay 13, 2025
Investor Day (January 2025)Investor day126 slidesJan 28, 2025
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference28 slidesJanuary 2025
Investor Presentation (January 2024)Investor deck28 slidesJan 8, 2024
JP Morgan Healthcare Conference 2023Conference20 slidesJan 9, 2023
Investor Presentation (January 2022)Investor deck19 slidesJan 11, 2022

Open Decks

Financings

RaiseDate
At-the-market programme of at-the-market (ATM) offering program
Cancelled: at-the-market programme
Feb 20, 2025
Public offering of common stock
Closed: US$74.8M raised · US$10 a share · J.P. Morgan +4
Dealers: J.P. Morgan (co-lead), Cantor (co-lead), Wells Fargo Securities (co-lead), Leerink Partners (co-lead), Lake Street Capital Markets
Use of proceeds: About $49.5 million to repurchase 5,270,845 shares held by KCK Ltd.; rest for general corporate purposes incl. R&D, SG&A, debt reduction, working capital
Feb 18, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$17.00 a share on Apr 21, 2021.

Price
US$17.00 a share
Shares offered
6,000,000 shares of common stock
Offering size
US$102 million
Underwriters' option
Up to 900,000 more shares
Listing
NPCE on the Nasdaq Global Market
Underwriters
J.P. Morgan, Morgan Stanley, Wells Fargo Securities, SVB Leerink · In the order on the cover
Shares delivered
On or about Apr 26, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceJan 29, 2021
Filed publiclyMar 24, 2021
Amended twiceNewest Apr 21, 2021
Shares registered with an exchangeApr 14, 2021
Declared effective by the SECApr 21, 2021
Final prospectus, with the priceApr 23, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Apr 23, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue100.0M79.9M65.4M45.5M45.2M41.1M37.0M
Cost of revenue22.8M20.8M17.3M13.0M11.7M10.9M10.5M
Gross profit77.2M59.1M48.1M32.5M33.4M30.3M26.5M
Research and development27.9M23.7M20.8M21.9M18.2M15.7M18.3M
Selling, general and administrative19.1M57.1M54.5M51.3M39.0M27.6M30.2M
Operating income-16.3M-21.7M-27.2M-40.8M-23.7M-13.1M-22.0M
Depreciation and amortization238.0K207.0K172.0K267.0K296.0K312.0K421.0K
EBITDA-16.1M-21.5M-27.0M-40.5M-23.4M-12.7M-21.6M
Interest expense7.46M8.80M8.52M7.53M7.41M11.5M9.48M
Income before tax-21.5M-27.1M-33.0M-47.1M-36.1M-24.3M-30.0M
Income tax01.44M6.29M2.03M11.7M10.8M
Net income-21.5M-27.1M-33.0M-47.1M-36.1M-24.3M-30.0M
Earnings per share, basic-0.66-0.93-1.27-1.91-2.17-117.85-2.70
Earnings per share, diluted-0.66-0.93-1.27-1.91-2.17-117.85

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents21.7M13.4M18.1M6.61M19.2M26.4M4.12M
Short-term investments39.4M39.3M48.4M70.8M96.4M11.7M969.0K
Receivables12.9M12.9M12.3M7.48M7.09M8.39M6.02M
Inventory14.9M13.4M11.2M9.71M7.82M6.91M7.90M
Current assets94.1M81.3M92.7M97.7M132.8M54.6M20.3M
Property, plant and equipment1.13M1.05M1.00M1.06M603.0K515.0K810.0K
Total assets105.6M94.6M107.7M114.1M133.6M56.0M21.1M
Accounts payable1.78M2.95M2.33M2.15M1.38M949.0K903.0K
Current liabilities17.8M15.2M16.2M11.0M9.30M9.60M75.1M
Long-term debt58.9M59.5M57.0M52.9M49.8M50.8M
Total debt58.9M59.5M57.0M52.9M49.8M52.9M62.8M
Total liabilities86.5M86.6M87.0M79.3M60.1M62.4M150.4M
Shareholders' equity19.0M8.01M20.7M34.8M73.5M-147.8M-129.3M
Shares outstanding33.6M30.1M27.8M25.0M24.5M314.1K11.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-11.0M-17.9M-19.7M-36.9M-24.6M-21.6M-25.0M
Capital spending-332.0K-306.0K-173.0K-603.0K-384.0K-62.0K-468.0K
Free cash flow-11.3M-18.3M-19.9M-37.5M-25.0M-21.7M-25.5M
Cash from investing-332.0K8.99M23.0M23.8M-85.4M-10.8M3.62M
Cash from financing19.6M4.33M8.13M490.0K102.5M55.0M21.4M
Share buybacks-49.5M0-259.0K-59.0K106.6M
Change in cash8.26M-4.63M11.5M-12.6M-7.45M22.6M-38.0K

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 21, 2026Insider tradeSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 4, 2026Big-stake noticeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 28, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
8-K · Current reportAug 11, 2026ResultsSEC
8-K · Current reportJul 28, 2026Current reportSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Meeting outcomeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 12, 2026ResultsSEC
ARS · Annual report to shareholdersApr 21, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 21, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2026Meeting noticeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 23, 2026Insider tradeSEC
4 · Change in ownershipMar 23, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 3, 2026Offer documentSEC
10-K · Annual reportMar 3, 2026Annual reportSEC
8-K · Current reportMar 3, 2026ResultsSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipDec 23, 2025Insider tradeSEC
4 · Change in ownershipDec 23, 2025Insider tradeSEC
4 · Change in ownershipDec 23, 2025Insider tradeSEC
4 · Change in ownershipDec 23, 2025Insider tradeSEC
144 · Notice of proposed saleDec 15, 2025Other filingsSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 3, 2025Big-stake noticeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 5, 2025Big-stake noticeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
8-K · Current reportJun 24, 2025Management or board changeSEC
8-K · Current reportJun 12, 2025Meeting outcomeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
8-K · Current reportJun 4, 2025Material contractSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
8-K · Current reportMay 27, 2025Current reportSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
4 · Change in ownershipApr 23, 2025Insider tradeSEC
4 · Change in ownershipApr 23, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 22, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 22, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 22, 2025Meeting noticeSEC
8-K · Current reportApr 14, 2025Current reportSEC
8-K · Current reportApr 2, 2025Current reportSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 4, 2025Offer documentSEC
10-K · Annual reportMar 4, 2025Annual reportSEC
8-K · Current reportMar 4, 2025ResultsSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
8-K · Current reportFeb 20, 2025Current reportSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
8-K · Current reportFeb 18, 2025Current reportSEC
424B5 · ProspectusFeb 18, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
8-K · Current reportFeb 14, 2025Material contractSEC
424B5 · ProspectusFeb 14, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2025Big-stake noticeSEC
4 · Change in ownershipJan 31, 2025Insider tradeSEC
144 · Notice of proposed saleJan 30, 2025Other filingsSEC
144 · Notice of proposed saleJan 29, 2025Other filingsSEC
4 · Change in ownershipJan 28, 2025Insider tradeSEC
8-K · Current reportJan 28, 2025ResultsSEC
144 · Notice of proposed saleJan 24, 2025Other filingsSEC
8-K · Current reportJan 15, 2025Current reportSEC
4 · Change in ownershipJan 8, 2025Insider tradeSEC
3 · Initial statement of ownershipJan 8, 2025Insider tradeSEC
8-K · Current reportJan 8, 2025ResultsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024ResultsSEC
SCHEDULE 13G · Big-stake noticeNov 4, 2024Big-stake noticeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
144 · Notice of proposed saleOct 28, 2024Other filingsSEC
4 · Change in ownershipOct 24, 2024Insider tradeSEC
4 · Change in ownershipOct 22, 2024Insider tradeSEC
4 · Change in ownershipOct 18, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 3, 2024Big-stake noticeSEC
4 · Change in ownershipOct 3, 2024Insider tradeSEC
144 · Notice of proposed saleOct 3, 2024Other filingsSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
8-K · Current reportJun 10, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
4 · Change in ownershipApr 26, 2024Insider tradeSEC
4 · Change in ownershipApr 23, 2024Insider tradeSEC
ARS · Annual report to shareholdersApr 22, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 22, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 22, 2024Meeting noticeSEC
4 · Change in ownershipApr 18, 2024Insider tradeSEC
4 · Change in ownershipApr 15, 2024Insider tradeSEC
144 · Notice of proposed saleMar 15, 2024Other filingsSEC
S-8 · Registration statement for employee plansMar 5, 2024Offer documentSEC
10-K · Annual reportMar 5, 2024Annual reportSEC
8-K · Current reportMar 5, 2024ResultsSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
8-K · Current reportFeb 7, 2024Management or board changeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 1, 2024Insider tradeSEC
4 · Change in ownershipJan 26, 2024Insider tradeSEC
8-K · Current reportJan 8, 2024ResultsSEC
4 · Change in ownershipDec 28, 2023Insider tradeSEC
4 · Change in ownershipDec 22, 2023Insider tradeSEC
144 · Notice of proposed saleDec 20, 2023Other filingsSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
144 · Notice of proposed saleDec 6, 2023Other filingsSEC

This page holds 200 of 358 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from NeuroPace, Inc.’s releases · as of Nov 10, 2026

Common shares
34,451,570
Fully diluted
34,451,570

Fully diluted

LineSharesAs of
Common shares34,451,570Nov 10, 2026

Share count over time

CountShares
Nov 10, 202634,451,570

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
First Light Asset Management, LLC3.98M11.6%US$54.8MSep 30, 2026
Polar Capital Holdings Plc3.3M9.6%US$45.4MSep 30, 2026
Soleus Capital Management, L.P.3.22M9.3%US$44.3MSep 30, 2026
Morgan Stanley2.57M7.5%US$35.3MSep 30, 2026
BlackRock2.47M7.2%US$34MSep 30, 2026
Vanguard1.66M4.8%US$22.8MSep 30, 2026
Driehaus Capital Management LLC1.43M4.1%US$19.7MSep 30, 2026
Orbimed Advisors LLC1.06M3.1%US$14.5MSep 30, 2026
DWS936K2.7%US$12.9MSep 30, 2026
Armistice Capital, LLC800K2.3%US$11MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Geode Capital662K1.9%US$9.11MSep 30, 2026
State Street567K1.6%US$7.8MSep 30, 2026
Silvercrest Asset Management Group LLC314K0.91%US$4.33MSep 30, 2026
Qube Research & Technologies Ltd304K0.88%US$4.18MSep 30, 2026
D. E. Shaw & Co., Inc.263K0.76%US$3.62MSep 30, 2026
Northern Trust259K0.75%US$3.56MSep 30, 2026
Citadel247K0.72%US$3.4MSep 30, 2026
Essex Investment Management Co LLC202K0.59%US$2.78MSep 30, 2026
Bank of America180K0.52%US$2.48MSep 30, 2026
Palumbo Wealth Management LLC168K0.49%US$2.31MSep 30, 2026
Algert Global LLC165K0.48%US$2.26MSep 30, 2026
HighMark Wealth Management LLC163K0.47%US$2.24MSep 30, 2026
JPMorgan154K0.45%US$2.15MSep 30, 2026
Tudor Investment Corp Et Al143K0.42%US$1.97MSep 30, 2026
Goldman Sachs140K0.41%US$1.92MSep 30, 2026
Lazard Asset Management LLC126K0.37%US$1.74MSep 30, 2026
Nuveen114K0.33%US$1.56MSep 30, 2026
BNP Paribas86,7050.25%US$1.19MSep 30, 2026
Schwab77,8790.23%US$1.07MSep 30, 2026
XTX Topco Ltd67,0780.19%US$923KSep 30, 2026
Legato Capital Management LLC62,6330.18%US$862KSep 30, 2026
Panagora Asset Management Inc59,9740.17%US$825KSep 30, 2026
Russell Investments Group, Ltd.59,1970.17%US$815KSep 30, 2026
BNY56,5010.16%US$777KSep 30, 2026
Millennium51,0780.15%US$703KSep 30, 2026
Gsa Capital Partners LLP44,0050.13%US$606KSep 30, 2026
Renaissance Technologies43,7000.13%US$601KSep 30, 2026
Sei Investments Co38,6670.11%US$532KSep 30, 2026
Barclays37,0890.11%US$510KSep 30, 2026
Rhumbline Advisers32,1100.09%US$442KSep 30, 2026
AQR Capital Management LLC31,9440.09%US$440KSep 30, 2026
Squarepoint Ops LLC31,5110.09%US$434KSep 30, 2026
Point72 Asset Management, L.P.28,8430.08%US$397KSep 30, 2026
State Of Wisconsin Investment Board26,1480.08%US$360KSep 30, 2026
Polar Asset Management Partners Inc.25,6000.07%US$352KSep 30, 2026
Quadrature Capital Ltd24,4020.07%US$336KSep 30, 2026
UBS24,2280.07%US$333KSep 30, 2026
Integrated Quantitative Investments LLC23,4130.07%US$322KSep 30, 2026
Western Wealth Management, LLC22,9500.07%US$316KSep 30, 2026
EntryPoint Capital, LLC22,8500.07%US$314KSep 30, 2026

This page holds 50 of 101 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund908K2.6%US$14.4MJun 30, 2026
iShares Russell 2000 ETF689K2.0%US$10.9MJun 30, 2026
Vanguard Extended Market Index Fund290K0.84%US$4.61MJun 30, 2026
Fidelity Small Cap Index Fund288K0.84%US$3.71MJul 31, 2026
iShares Russell 2000 Growth ETF249K0.72%US$3.96MJun 30, 2026
BlackRock Advantage Small Cap Core Fund227K0.66%US$3.76MMay 29, 2026
Fidelity Small Cap Growth Fund210K0.61%US$2.71MJul 31, 2026
Driehaus Micro Cap Growth Fund175K0.51%US$2.78MJun 30, 2026
Vanguard Russell 2000 Index Fund131K0.38%US$2.17MMay 31, 2026
Fidelity Extended Market Index Fund126K0.37%US$2.08MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fidelity Small Cap Growth K6 Fund108K0.31%US$1.39MJul 31, 2026
North Square Dynamic Small Cap Fund91,6630.27%US$1.52MMay 31, 2026
iShares Micro-Cap ETF89,0940.26%US$1.42MJun 30, 2026
Adara Smaller Companies Fund85,1210.25%US$1.41MMay 31, 2026
Schwab Small-Cap Index Fund64,4710.19%US$831KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account58,0530.17%US$922KJun 30, 2026
1290 Essex Small Cap Growth Fund50,8040.15%US$655KJul 31, 2026
Master Small Cap Index Series49,5430.14%US$787KJun 30, 2026
Fidelity Total Market Index Fund45,6380.13%US$755KMay 31, 2026
Small Cap Equity Fund44,2160.13%US$703KJun 30, 2026
BlackRock Advantage Small Cap Growth Fund42,6550.12%US$678KJun 30, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF39,6570.12%US$630KJun 30, 2026
Small Company Growth Portfolio37,6440.11%US$598KJun 30, 2026
Fidelity Series Total Market Index Fund37,2810.11%US$617KMay 31, 2026
Tax-Managed U.S. Mid & Small Cap Fund37,0560.11%US$478KJul 31, 2026
Strategic Advisers U.S. Total Stock Fund36,2860.11%US$600KMay 31, 2026
Nuveen Small Cap Blend Index Fund34,9660.10%US$451KJul 31, 2026
Destinations Small-Mid Cap Equity Fund29,6610.09%US$491KMay 31, 2026
EQ/2000 Managed Volatility Portfolio28,7000.08%US$456KJun 30, 2026
BlackRock Advantage SMID Cap Fund, Inc.25,3850.07%US$403KJun 30, 2026
Fidelity Small Cap Growth Index Fund24,8320.07%US$395KJun 30, 2026
Fidelity Nasdaq Composite Index Fund24,2690.07%US$401KMay 31, 2026
Vanguard Russell 2000 Growth Index Fund23,8280.07%US$394KMay 31, 2026
Goldman Sachs Absolute Return Tracker Fund19,0940.06%US$303KJun 30, 2026
LVIP State Street Small-Cap Index Fund17,6000.05%US$280KJun 30, 2026
Vanguard Balanced Index Fund15,2340.04%US$242KJun 30, 2026
Diversified Equity Alpha Master Portfolio15,0990.04%US$240KJun 30, 2026
Small Cap Index Fund13,6390.04%US$217KJun 30, 2026
Schwab Total Stock Market Index Fund13,3560.04%US$172KJul 31, 2026
Vanguard Institutional Total Stock Market Index Fund13,0810.04%US$208KJun 30, 2026
Fidelity ZERO Total Market Index Fund13,0490.04%US$168KJul 31, 2026
Global X Russell 2000 ETF12,6740.04%US$163KJul 31, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF12,1120.04%US$200KMay 31, 2026
iShares Russell 3000 ETF11,1210.03%US$177KJun 30, 2026
Small Cap Core Fund11,0620.03%US$176KJun 30, 2026
U.S. Small Cap Equity Fund10,0460.03%US$160KJun 30, 2026
Small Cap Index Fund9,5300.03%US$158KMay 31, 2026
MetLife Russell 2000 Index Portfolio9,2290.03%US$147KJun 30, 2026
Fidelity ZERO Extended Market Index Fund9,1800.03%US$118KJul 31, 2026
Zacks Small-Cap Core Fund9,1360.03%US$151KMay 31, 2026

This page holds 50 of 112 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Huennekens R Scott
Director
Buy12,500USD 8.29US$104KNov 18, 2026
Becker Joel
Director, Officer: CHIEF EXECUTIVE OFFICER
Buy11,891USD 8.35US$99,293Nov 17, 2026
Williams Patrick F.
Officer: Chief Financial Officer
Buy11,891USD 8.34US$99,148Nov 17, 2026

Big stakes

StakeStakeSharesDateFiling
First Light Asset Management, LLC12.25%4.2MAug 31, 2026Schedule 13G
Polar Capital Holdings Plc9.13%2.97MMar 31, 2025Schedule 13G
Soleus Capital Management, L.P.8.90%2.95MSep 30, 2025Schedule 13G
Morgan Stanley8.30%2.49MDec 31, 2024Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Scott Huennekens
Other companies: QuidelOrtho Corporation (Director · Since at least Dec 6, 2024); Envista Holdings Corporation (Director · Since at least Sep 20, 2019); Hyperfine, Inc. (Director · Dec 22, 2021 – Jun 12, 2024 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); NuVasive Inc (Director · Oct 1, 2018 – Sep 1, 2023 · Past); EndoChoice Holdings Inc (Director · Jun 5, 2015 – Nov 22, 2016 · Past); Bellerophon Therapeutics Inc (Director · May 12, 2015 – May 12, 2015 · Past); Volcano Corp (President & Chief Executive Of, Director · Jun 14, 2006 – Feb 17, 2015 · Past)
Director · Since at least Jan 6, 2025
Frank M Fischer
Other companies: Tenon Medical, Inc. (Director · Apr 26, 2022 – May 22, 2023 · Past); Nevro Corp (Director · Nov 5, 2014 – Mar 31, 2024 · Past); Intralase Corp (Director · May 24, 2006 – Apr 2, 2007 · Past)
Director · Since at least Apr 20, 2021
Joseph Lacob
Other companies: Align Technology, Inc. (Director · Since at least May 24, 2006); Orexigen Therapeutics Inc (Director · Apr 25, 2007 – May 27, 2011 · Past); eHealth, Inc. (Director · Oct 12, 2006 – Nov 8, 2007 · Past)
Director · Since at least Apr 20, 2021
Patrick F. Williams
Other companies: BioRestorative Therapies, Inc. (Director · Nov 4, 2021 – Feb 14, 2025 · Past); STAAR Surgical Company (Chief Financial Officer · Jul 6, 2020 – Mar 12, 2025 · Past); Sientra Inc (General Manager miraDry & SVP · Jan 19, 2018 – Aug 6, 2018 · Past)
Chief Financial Officer · Since at least Jun 20, 2025
Joel D. Becker
Other companies: Integer Holdings Corporation (President, CRM & Neuro · Apr 22, 2019 – Apr 22, 2022 · Past); St. Jude Medical Inc (President, Americas · Oct 31, 2011 – Dec 17, 2015 · Past)
CEO and Board Member · Since at least Jul 10, 2023
Rakhi Kumar
Other companies: Amanat Acquisition Corp (Director · Since at least May 18, 2026); Roivant Sciences Ltd. (Chief Accounting Officer · Oct 24, 2023 – Feb 20, 2025 · Past)
Director · Since at least Jun 7, 2024
Uri Geiger
Other companies: STRATA Skin Sciences, Inc. (Director · Jul 15, 2024 – Jul 15, 2024 · Past); Minerva Surgical, Inc. (Director · Feb 9, 2023 – Feb 9, 2023 · Past)
Director · Since at least Jan 5, 2023
Greg Shaw Garfield
Other companies: Semler Scientific Inc (Director · Feb 20, 2014 – Feb 18, 2016 · Past)
Director · Apr 20, 2021 – Jun 13, 2022 · Past
Evan NortonDirector · Apr 20, 2021 – Apr 26, 2021 · Past
Irina RidleyChief Legal Officer/Secretary · Apr 20, 2021 – Feb 20, 2023 · Past
All 17 people
PersonSeat
Leah AkinGeneral Counsel & Corporate Secretary · Since at least Nov 5, 2026
Lisa AndradeDirector · Since at least Jun 7, 2024
Martha MorrellChief Medical Officer · Since at least Apr 20, 2021
Michael FavetChief Executive Officer, Director · Apr 20, 2021 – Feb 21, 2023 · Past
Rebecca KuhnCHIEF FINANCIAL OFFICER · Since at least Apr 20, 2021
Renee RyanDirector · Since at least Apr 20, 2021
Scott SchaperHead of Investor Relations · Since at least Sep 1, 2026

Open People

Log in to ask 6ix AI your own questions about NeuroPace, Inc.